Explore the vast range of titles available.

This study aimed at: (1) Reporting COVID‐19 symptoms and duration in professional football players; (2) comparing players’ pulmonary function before and after COVID‐19; (3) comparing players’ metabolic power (Pmet) before and after COVID‐19. Thirteen male players (Age: 23.9 ± 4.0 years, V̇O2peak: 49.7 ± 4.0 mL/kg/min) underwent a medical screening and performed a running incremental step test and a spirometry test after COVID‐19. Spirometric data were compared with the ones collected at the beginning of the same season. Players’ mean Pmet of the 10 matches played before COVID‐19 was compared with mean Pmet of the 10 matches played after COVID‐19. Players completed a questionnaire on COVID‐19 symptoms and duration 6 months following the disease. COVID‐19 positivity lasted on average 15 ± 5 days. “General fatigue” and “muscle fatigue” symptoms were reported by all players during COVID‐19 and persisted for 77% (general fatigue) and 54% (muscle fatigue) of the players for 37 ± 28 and 38 ± 29 days after the disease, respectively. No significant changes in spirometric measurements were found after COVID‐19, even though some impairments at the individual level were observed. Conversely, a linear mixed‐effects model analysis showed a significant reduction of Pmet (−4.1 ± 3.5%) following COVID‐19 (t = −2.686, p < 0.05). “General fatigue” and “muscle fatigue” symptoms may persist for several weeks following COVID‐19 in professional football players and should be considered for a safer return to sport. Players’ capacity to compete at high intensities might be compromised after COVID‐19. “General fatigue” and “muscle fatigue” symptoms were the most common long‐term COVID‐19 symptoms reported. Players’ capability to exercise at high intensity was compromised following COVID‐19. Players’ pulmonary function was not affected by COVID‐19, even though some impairments were observed at the individual level.

This project aims to test for the presence of structural breaks in the volatility of the European markets during the COVID-19 pandemic. A dataset composed by 19 sectoral indexes, and the methodology proposed by Kokoszka and Leipus are used. The results show that all the analyzed sectors besides two are going through multiple breaks. The breaks are more frequent during the beginning of the pandemic, and also the volatility is significantly higher during this period.

The study in question aims to analyze and describe the performative model of the kettlebell sport. The kettlebell sport is a weight lifting discipline in which the goal is to carry out as many repetitions as possible in the exercises of clean and jerk, biathlon (jerk and snatch) in the 10 minutes provided by the regulation. Four athletes of the agonist Umbria Kettlebell Training Center Team (3 men and 1 woman) were analyzed, respectively in the male biathlon (jerk 70+70 lbs and snatch 70 lbs), male biathlon under 18 (jerk 53+53 lbs and snatch 53 lbs), male clean and jerk (62+62 lbs) and female snatch (53 and 35 lbs). The investigation area is made up of three parts: anthropometric analysis, physiological analysis, electromyography analysis. The main results of the tests are the following: it is a form of weight lifting on aerobic regime (Vo2 max 40,4 ± 5,9 ml/kg/min, Average Heart Rate 162 ± 14 bpm, Max Ventilation 111,6 ± 29,6 l/min, End of test Ematic Lactate 3,3 ± 0,29 mmol/l) at which, in order to excelle and being able to perform, effective and efficient, an optimal technique is needed to make the best use of the available energy and organic reserves avoiding any over-use injuries due to the loads lifted. The analysis of the macrocycles' training in fact, tell us the kettlebell is a sport that requires high load volumes, at which the tonnage average per training is 19K pounds circa in the elite biathlon, 17K pounds in the under 18, 12K pounds in clean and jerk and 10K pounds in the female snatch (excluding auxiliary exercises in all cases). The electromyographic analysis show that the exercise which requires the greatest muscular recruitment of both the anterior and posterior muscular kinetic chain is the clean and jerk, while the snatching exercise, being unilateral, involves the crossed muscular kinetic chains. Further tests on a larger sample of athletes are needed to verify and eventually correct the assessments made of the study in question.

Hematopoietic stem and progenitor cells (HSPC) reside in the bone marrow (BM) niche and serve as a reservoir for mature blood cells throughout life. Aging in the BM is characterized by low‐grade chronic inflammation that could contribute to the reduced functionality of aged HSPC. Mesenchymal stromal cells (MSC) in the BM support HSPC self‐renewal. However, changes in MSC function with age and the crosstalk between MSC and HSPC remain understudied. Here, we conducted an extensive characterization of senescence features in BM‐derived MSC from young and aged healthy donors. Aged MSC displayed an enlarged senescent‐like morphology, a delayed clonogenic potential and reduced proliferation ability when compared to younger counterparts. Of note, the observed proliferation delay was associated with increased levels of SA‐β‐galactosidase (SA‐β‐Gal) and lipofuscin in aged MSC at early passages and a modest but consistent accumulation of physical DNA damage and DNA damage response (DDR) activation. Consistent with the establishment of a senescence‐like state in aged MSC, we detected an increase in pro‐inflammatory senescence‐associated secretory phenotype (SASP) factors, both at the transcript and protein levels. Conversely, the immunomodulatory properties of aged MSC were significantly reduced. Importantly, exposure of young HSPC to factors secreted by aged MSC induced pro‐inflammatory genes in HSPC and impaired HSPC clonogenic potential in a SASP‐dependent manner. Altogether, our results reveal that BM‐derived MSC from aged healthy donors display features of senescence and that, during aging, MSC‐associated secretomes contribute to activate an inflammatory transcriptional program in HSPC that may ultimately impair their functionality. Aged mesenchymal stromal cells (MSC) display early senescence features including SA‐β‐Gal accumulation, DDR, and SASP activation. Through SASP, aged MSC impair the clonogenic potential of hematopoietic stem and progenitor cells (HSPC) and induce the activation of a pro‐inflammatory transcriptional program in young HSPC.

Neural stem progenitor cells (NSPCs) from E13.5 mouse embryos can be maintained in culture under proliferating conditions. Upon growth-factor removal, they may differentiate toward either neuronal or glial phenotypes or both. Exosomes are small extracellular vesicles that are part of the cell secretome; they may contain and deliver both proteins and genetic material and thus play a role in cell–cell communication, guide axonal growth, modulate synaptic activity and regulate peripheral nerve regeneration. In this work, we were interested in determining whether NSPCs and their progeny can produce and secrete extracellular vesicles (EVs) and if their content can affect cell differentiation. Our results indicate that cultured NSPCs produce and secrete EVs both under proliferating conditions and after differentiation. Treatment of proliferating NSPCs with EVs derived from differentiated NSPCs triggers cell differentiation in a dose-dependent manner, as demonstrated by glial- and neuronal-marker expression.

ABSTRACT Activating mutations in the BRAF-MAPK pathway have been reported in histiocytoses, hematological inflammatory neoplasms characterized by multi-organ dissemination of pro-inflammatory myeloid cells. Here, we generate a humanized mouse model of transplantation of human hematopoietic stem and progenitor cells (HSPCs) expressing the activated form of BRAF ( BRAF V600E ). All mice transplanted with BRAF V600E -expressing HSPCs succumb to bone marrow failure, displaying myeloid-restricted hematopoiesis and multi-organ dissemination of aberrant mononuclear phagocytes. At the basis of this aggressive phenotype, we uncover the engagement of a senescence program, characterized by DNA damage response activation and a senescence-associated secretory phenotype, which affects also non-mutated bystander cells. Mechanistically, we identify TNFα as a key determinant of paracrine senescence and myeloid-restricted hematopoiesis and show that its inhibition dampens inflammation, delays disease onset and rescues hematopoietic defects in bystander cells. Our work establishes that senescence in the human hematopoietic system links oncogene-activation to the systemic inflammation observed in histiocytic neoplasms. BRAF-MAPK activating mutations are reported in histiocytoses—hematological neoplasms with widespread pro-inflammatory myeloid cells. Here, the authors show that an activating mutant BRAF in haematopoietic stem and progenitor cells causes an oncogene-induced senescence response leading to myeloid restricted haematopoiesis, inflammation and histiocytosis.

Posidonia oceanica significantly contributes to the health of oceans and coastal areas; however, its progressive decline is becoming an increasing source of concern. The present preliminary study aims to assess the chemical parameters that describe the state of preservation of the aforementioned plant meadows located in the Tremiti Islands archipelago. To better understand the plants’ response to external factors, the emission of biogenic volatile organic compounds (BVOCs) was investigated using Posidonia oceanica as a biological indicator. Subsequently, the heavy metal concentrations (Ag, Al, As, Ba, Be, Cd, Co, Cr, Cu, Fe, Mn, Mo, Ni, Pb, Sb, Se, Sn, Ti, Tl, V, Zn) in sediments, leaves, and seawater were determined and pollution indicators were calculated to assess the deviation from the natural background levels of sediments. The dimethyl sulfoniopropionate (DMSP) to dimethyl sulfoxide (DMSO) ratio was calculated to evaluate the oxidative stress levels in the meadows because the DMSP naturally present in Posidonia oceanica is oxidized to DMSO and decreases the ratio of DMSP/DMSO. BVOC analysis revealed dimethyl sulphide (DMS) as the most abundant molecule. Morphological features led to variations in metal concentrations across sampling sites, with sheltered bays displaying a higher metal content. Degradation is indicated by a greater DMSO content in the outer leaves. In accordance with the metal content, the bioindicator ratio confirms greater degradation on the south side, which aligns with increased oxidative stress.

In pediatric liver recipients perioperative factors may affect respiratory and cardiac function, and prolong mechanical ventilation during post-operative period. The use of NAVA can improve the interaction between the patient and the ventilator from both a respiratory and cardiac perspective. The objective of this study is to evaluate the synchronization between the patient and the ventilator, as well as cardiac function, during the application of neurally adjusted ventilatory assist (NAVA) and pressure support ventilation (PSV) in pediatric liver transplant recipients. This is a single-center, prospective, randomized, physiological cross-over controlled trial conducted between 2021 and 2022. Children (1 month-10 years old) who underwent liver transplantation were admitted to the pediatric intensive care unit. Patients were randomised to one of two crossover sequences of ventilation trials of 40 min each (PSV/NAVA/PSV or NAVA/PSV/NAVA). Cardiac function was studied by echocardiogram. Twenty-four patients were enrolled and 21 completed the study. Primary outcomes were variation of asynchrony index (AI) and tricuspid annular plane systolic excursion (TAPSE) during the two ventilation modes. Secondary outcomes were patient-ventilator interaction parameters, gas exchange, left and right ventricular function, and hemodynamic parameters. NAVA compared to PSV: (1) improves patient-ventilator interaction reducing AI (coeff − 6.66 95% CI −11.5 to −1.78, p  = 0.008); (2) does not improve TAPSE (coeff 0.62 95% CI −1.49 to 2.74, p  < 0.557) No differences in terms of pulmonary gas exchange and hemodynamic parameters were detected. NAVA (when compared to PSV) improves patient-ventilator interaction in terms of asynchronies without affecting cardiac biventricular function. Trial registration : NCT 04792788, Registration date: 2021-03-11.